Dechra Pharmaceuticals PLC Director/PDMR Shareholding (7791Y)

TIDMDPH

RNS Number : 7791Y

Dechra Pharmaceuticals PLC

07 March 2017

7 March 2017

Dechra Pharmaceuticals PLC

(the Company)

Director Shareholding

The Company announces that on 7 March 2017 Richard Cotton, Chief Financial Officer, was granted the following awards over ordinary shares of 1 pence each in the Company. Each award will vest, subject to the satisfaction of a performance condition, on the date specified below:

 
  Type of award    Number of shares      Vesting date 
                    subject to award 
----------------  ------------------  ------------------ 
 Nil cost option        21,033          3 January 2018 
----------------  ------------------  ------------------ 
 Nil cost option        21,033         15 September 2018 
----------------  ------------------  ------------------ 
 

These are the recruitment awards referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2016.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  ------------------------------------------------------------ 
 a)   Name                           Richard Cotton 
---  -----------------------------  ----------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status                Director 
---  -----------------------------  ----------------------------- 
 b)   Initial notification/          Initial Notification 
       amendment 
---  -----------------------------  ----------------------------- 
 3.   Details of the Issuer 
---  ------------------------------------------------------------ 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ----------------------------- 
 b)   LEI code                       N/A 
---  -----------------------------  ----------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument                     ISIN: GB0009633180 
       Identification 
       code 
---  -----------------------------  ----------------------------- 
 b)   Nature of                      Grant of nil cost options 
       the transaction 
---  -----------------------------  ----------------------------- 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volumes(s) 
                                      Nil cost        21,033 
                                      Nil cost        21,033 
---  -----------------------------  --------------  ------------- 
 d)        Aggregated                 N/A 
            information 
             *    Aggregate volume 
 
 
             *    Price 
---  -----------------------------  ----------------------------- 
 e)   Date of the                    2017.03.07 
       transaction 
---  -----------------------------  ----------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  ----------------------------- 
 

For further information, please contact:

Suzana Cross, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKODDPBKDANK

(END) Dow Jones Newswires

March 07, 2017 10:18 ET (15:18 GMT)